Web Based Renal Transplant Patient Medication Education

Status Recruiting

Clinical Trial Summary

Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.

Clinical Trial Description

Transplant recipients are particularly vulnerable to medication errors because of the large number of chronic drugs needed to prevent rejection and treat comorbidities. Compliance failures directly compromise patient safety through acute immunologic events and premature graft loss. For society, the loss of invested fiscal and organic (organs) resources is catastrophic. As the unique constant in the chain of people who provide, modify and consume prescription medications, health information technology should be focused on empowering the patient to prevent medication errors. Our principal clinical hypothesis is that HIT can be proven to improve patient safety by minimizing medication errors. Specific aims address the creation of new knowledge and evidence ( in a renal transplant population) of benefits of widely applicable HIT tools. Web enabled education of two groups, new (<6 months) and established (> 6 months), kidney transplant recipients is proposed. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training

Related Conditions & MeSH terms

Renal Transplant Recipients

Clinical Trial Details

NCT number	NCT00327483
Study type	Interventional
Source	Agency for Healthcare Research and Quality (AHRQ)
Contact
Status	Recruiting
Phase	Phase 4
Start date	July 2005
Completion date	April 2006

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02956005` - Envarsus XR in African American Renal Transplant Recipients	N/A
Completed	`NCT01086904` - Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients	Phase 2
Completed	`NCT00319189` - Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients	Phase 4
Completed	`NCT01859832` - Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay	N/A
Recruiting	`NCT03110406` - Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation	N/A
Recruiting	`NCT02973464` - The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population	Phase 3
Active, not recruiting	`NCT03797196` - RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients	Phase 4
Terminated	`NCT01318915` - Research Study of ATG and Rituximab in Renal Transplantation	Early Phase 1
Terminated	`NCT00271830` - Sexual Function in Male Renal Transplant Patients	N/A
Completed	`NCT00138970` - Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk	Phase 4
Withdrawn	`NCT04903054` - Selective CD28 Blockade in Renal Transplant Recipients	Phase 2
Completed	`NCT02706678` - Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients	Phase 4
Active, not recruiting	`NCT04218721` - Implementing eHealth Interventions Into Regular Clinical Practice	N/A
Recruiting	`NCT03726307` - Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study	Phase 1